Nephros Receives initial FDA response to 510(k) Application for Hemodiafiltration System

RIVER EDGE, N.J., November 10, 2011 /PRNewswire-FirstCall/ — Nephros, Inc. (OTC
Bulletin Board: NEPH) announced that it has received the initial review by the Food and Drug Administration (“FDA”) of the 510(k) application for marketing clearance of the company’s hemodiafiltration system.
Read more of this entry

Advertisements

Tags: ,

Categories: Life Sciences Industry Network, LifeSciences - Hospitals and Medical Services, Research & Development

Author:NJ Tech Council

The New Jersey Tech Council helps companies grow and supports the tech, innovation and entrepreneurial ecosystems in the state and region.

NJTC TechWire

Daily updates about the region's most tech savvy companies

Trackbacks/Pingbacks

  1. Industry News » Blog Archive » Nephros Receives initial FDA response to 510(k) Application for Hemodiafiltration System - November 11, 2011

    […] more here: Nephros Receives initial FDA response to 510(k) Application for Hemodiafiltration System Tags: business, delicious, development, digital-video, energy, events, nephros inc., network, […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: